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Cytomegalovirus (CMV)1 is a herpesvirus whose genome consists of double-stranded 
DNA of approximately  l0  s daltons.  CMV  can cause acute disease  (1-10)  as well  as 
remain  latent  with  subsequent  activation  (11-14).  The  answers  to  basic  questions 
concerning the specific cells that  harbor CMV  in a  latent  state,  the mechanisms of 
activation of the virus, and the reasons for restricted cell tropism in vivo and in vitro 
are not known. 
Cytomegalovirus infection and latency can be studied  in mice. From such studies, 
we have learned that a subset of B lymphocytes harvested from the spleen, peritoneal 
macrophages,  and sperm cells can harbor  latent  murine  cytomegalovirus  (MCMV) 
(15-18).  Virus  can  be  activated  by allogeneic  eocultivation  of B  cells  (15,  17),  by 
procedures that activate macrophages (16), or by immunosuppression (19). In contrast, 
MCMV  could not be detected  in brain,  kidney, thymus, or liver cells from latently 
infected  mice by cocultivation  assays  or by DNA-DNA hybridization  kinetics.  Al- 
though the MCMV  genome was detected in splenic B cells, peritoneal  macrophages, 
and  reproductive  tissues  bY  nucleic  acid  hybridization  assay,  the  number  of cells 
involved was few, and, hence, studies on the molecular basis of latency and activation 
are  limited.  For this  reason,  there  is  a  need  to develop  an  in  vitro  model  of CMV 
latency. This would allow dissection of the molecular basis of cytomegalovirus latency 
and activation of virus and shed light on the restriction of cytomegalovirus to specific 
cell types. In this paper we present,  to our knowledge, the first such model of CMV 
latency and evaluate several of its parameters. 
Materials  and Methods 
Cells.  PCC4 cells are a subclone of the azaguanine-resistant  line PCC4 aza 1 (20, 21) and 
were obtained from W. Speers of the University of Colorado, Denver, Colo. (22). OTT6050AF 1 
BrdU cells are pluripotent  cells, but remain undifferentiated  in tissue culture  (23) and were 
obtained  from  K.  Huebner,  Wistar  Institute  of Anatomy and  Biology,  Philadelphia,  Pa. 
* Supported by U. S. Public Health Service grants AI 07007 and NS 12428. This is publication 2,458 
from the Department of Immunopathology, Scripps Clinic and Research Foundation, La Jolla, California 
92037. 
1 Abbreviations used in this paper: CMV, cytomegalovirus; DMA, dimethylaeetamide; FCS, fetal calf serum; 
FITC, fluorescein isothyocyanate; HSV, herpes simplex virus; LCMV, lymphocytic choriomeningitis virus; 
MCMV, murine cytomegalovirus; MEF, mouse embryo fibroblasts; MEM, minimal essential medium; 
MOI, multiplicity of infection; PBS, phosphate-buffered saline; PFU, plaque-forming units; PIPES, 1,4- 
piperazinediethane sulfonic acid; SDS, sodium dodecyl sulfate; TNE, 50 mM Tris, pH 7.4, 1,')0 mM NaCI, 
1 mM EDTA; TNM, 0.01 M Tris, 0.14 M NaCI, 0.0015 M MgCI2,  pH 7.4; VSV, vesicular stomatitis virus. 
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OTTF12 cells are a differentiated line established from the same pluripotent stem cell line from 
which the O'["I'6050AF1 BrdU line was cloned (23) and were also obtained from K. Huebner. 
F9 cells (24) were obtained from G. Miller, Yale Medical School, New Haven, Conn., and were 
maintained in gelatin-coated flasks as described (25).  The parietal yolk sac line (PSY2)  was 
obtained from J.  Lehman  (University of Colorado Medical Center,  Denver, Colo.).  Mouse 
embryo fibroblasts were established by trypsinization of embryos from BALB/St mice. 
PCC4  and  PYS2 cells were propagated in Auto Pow  minimal essential medium  (MEM) 
(Flow Laboratories, Inc. Rockville, Md.) supplemented with 10% heat-inactivated (56°C for 30 
min) fetal calf serum (FCS). OTT6050AF1 BrdU and OTTF12 cells were propagated in RPMI 
1640 medium (Flow Laboratories, Inc.) supplemented with 10% heat-inactivated FCS. F9 cells 
were propagated in Dulbecco's modified Eagle's medium with 4.5 g glucose/liter and supple- 
mented  with  10%  heat-inactivated  FCS.  Mouse  embryo  cells were  propagated  in  MEM 
supplemented with 10% heat-inactivated calf serum. Monolayer cultures were grown in plastic 
flasks and dishes (Falcon Labware Co., Div. of Becton, Dickinson & Co., Oxnard, Calif.) at 
37°C and 6% COs in air, Cultures were subcultured after dispersion with 0.25%  trypsin-0.02% 
EDTA. Suspension cultures of PCC4 cells were initiated with 5 ×  106 cells in 50 ml MEM in 
250-ml  Erlenmeyer  flasks with  airtight  rubber  stoppers  and  were  cultured  at  37°C  on  a 
Gyrotory shaker, model G2 (New Brunswick Scientific Co., Inc., Edison, N. J.) rotating at 80 
rpm.  For experiments, monolayer cultures were seeded with 9  ×  105 cells/75-cm  2 flask. To 
induce cell differentiation,  10  mM  dimethylacetamide (DMA;  Aldrich Chemical Co.,  Inc., 
Milwaukee, Wis., dissolved in MEM) was added to the culture medium. 
Viruses.  MCMV source, handling, and characteristics have been reported (15-18). Virus 
stocks were maintained by passage in BALB/St mouse embryo fibroblasts, and the plaque assay 
was performed in mouse embryo cells propagated in 60-mm dishes. Lymphocytic choriomen- 
ingitis virus (LCMV), strain Armstrong, was passaged in baby hamster kidney (BHK 21) cells, 
and  infectious virus was plaqued in Vero cells as described (26).  Vesicular stomatitis virus 
(VSV), strain Indiana (Mudd Summers), was obtained from J. Holland, University of Califor- 
nia, San  Diego, Calif. Virus stocks were prepared in BHK21  cells, and  infectious virus was 
plaqued in Vero cells. Herpes simplex virus type  1 (HSV-1)  was obtained from A. Notkins, 
National Institutes of Health, Bethesda, Md.  HSV-1  was passaged and infectious virus was 
plaqued in human foreskin fibroblasts. 
Microcytotoxicity Absorption.  PCC4 cells propagated with or without dimethylacetamide (10 
raM)  were  dispersed  with  phosphate-buffered  saline  (PBS)  containing  0.02%  EDTA.  As 
controls, spleen cells from 129/J (H-2  b) or C3H/St (H-2  k) mice were included. Various numbers 
of cells were used to absorb for 30 rain at 4°C, a concentration ofcongenic mouse antiserum to 
H-2  b that would ordinarily lyse 90% of target cells expressing H-2  b antigens (EL4 cells). The 
absorbed sera were then examined for guinea pig complement-dependent lysis of EL4 cells as 
described (27). 
Binding of[aH]MCMV to Cells.  all-labeled MCMV was produced by adding [aH]thymidine 
(New England Nuclear, Boston, Mass.) to MCMV-infected mouse embryo fibroblasts. Virus 
was purified by equilibrium centrifugation in a 20-60% (vol/vol) Renografin (E. R. Squibb & 
Sons, Princeton, N. J.) in TNE (50 mM Tris, pH 7.4,  100 mM NaCI, 1 mM EDTA) gradients. 
The  purified preparation of aH-MCMV  contained approximately 10  s cpm per  108  plaque- 
forming units (PFU) of virus. 2 ×  108 cells (PCC4 cells propagated in the presence and absence 
of 10 mM DMA for 4 d, or mouse embryo fibroblasts) were exposed for various lengths of time 
at 37°C to 50,000 cpm of [aH]MCMV. The cells were centrifuge-washed five times, lysed by 
resuspension in  1% sodium dodecyl sulfate (SDS), and added to a  scintillation cocktail. The 
radioactivity was determined in a scintillation counter. 
Transport of MCMV DNA to the Nucleus.  [aH]Thymidine-labeled MCMV was produced and 
purified as described above. Undifferentiated or differentiated PCC4 cells were infected with 
20,000 cpm of [SH]MCMV at a  multiplicity of infection (MOI) of 5. At various times after 
infection, the cells were dispersed (and virions attached to the cell surface were removed) by 
treatment with 0.25%  trypsin in PBS for 5 min at 37°C. The cells were pelleted and washed 
twice with TNMbuffer (0.01  M Tris, 0.14 M  NaC1, 0.0015 M  MgC12, pH 7.4). The cells were 
disrupted by resuspension in 0.1%  Nonidet P-40 nonionic detergent (Shell Oil Co.) in TNM 
buffer. After 10 min at 4°C, the nuclei were pelleted at  1,500 g for 5 rain. The trichloroacetic 1638  LATENT CYTOMEGALOVIRUS INFECTION OF UNDIFFERENTIATED CELLS 
acid-precipitable radioactivity in  the  supernatant  (cytoplasm)  and  the  pellet  (nuclei)  was 
determined. 
Indirect Immunofluorescence Assay.  Cells grown on cover slips were washed with PBS and then 
fixed with ether-ethanol (1:1) for 10 min. After being washed in 95% ethanol for 20 min and 
airdryed, the cells on the cover slips were  treated first at 37°C for 30 min with monospecific 
mouse  antibodies to  MCMV  and  then  with  fluorescein isothiocyanate  (FITC)-conjugated 
monospecific rabbit anti-mouse IgG. After five washes with PBS, the ceils were mounted with 
PBS-glycerol  (9:1) and examined with a fluorescence microscope (Carl Zeiss, Inc., New York). 
Negative controls consisted of uninfected cells treated first with mouse antibodies to MCMV 
and then with FITC-conjugated rabbit anti-mouse IgG, as well as of infected cells treated first 
with nonimmune mouse serum and then with FITC-conjugated rabbit anti-mouse IgG. The 
specificity of the antibodies used and their production and conjugation to FITC have been 
detailed (15, 28). 
MCMV DNA-Cellular  DNA Hybridization Analysis.  DNA was isolated from cells by the 8 M 
urea-phosphate method as described (16). In brief, cells were lysed in 0.24 M phosphate buffer 
with 2% SDS, and proteins were digested with proteinase K  (E.  M.  Laboratories, Fullerton, 
Calif.; 500/xg/ml). Nucleic acids were extracted with phenol and adsorbed to hydroxylapatite 
(Bio-Rad Laboratories, Richmond, CaIif.).  DNA was  eluted with 0.48  M  phosphate buffer, 
dialyzed against  10  -3 M  EDTA (pH 8),  lyophilized to a  1.0-ml volume, and sonieated to a 
fragment size of 6-8S. DNA samples were analyzed for MCMV genome equivalents per cell by 
a phenol emulsion hybridization technique (18, 29). In brief, 0.1 ml samples containing 50 ~g 
DNA/ml  (optical  density of  1.0  at  260  nm),  0.48  M  phosphate  buffer  (pH  7),  MCMV 
[3H]DNA  (nick-translated to  10 7 cpm//xg DNA), and 9%  (vol/vol) phenol were denatured at 
110°C for 1 min. Samples were cooled in an ice bath and then mixed at room temperature on 
a Vortex mixer (American Scientific Products, McGaw Park, Ill.).  10-p.l samples were removed 
at  various times, and the radioactivity in single- and double-stranded DNA was  assayed by 
hydroxylapatite chromatography (15). 
MCMV DNA-CeUular RNA Hybridization Analysis.  Cytoplasmic RNA was prepared from cells 
by  Triton N101  (Sigma  Chemical  Co.,  St.  Louis,  Mo.)  lysis  and  extraction with  phenol- 
chloroform-sodium dodecyl sulfate, as described (30). RNA was precipitated with ethanol at 
-20°C. Cellular RNA samples were analyzed for MCMV RNA by MCMV [3H]DNA-cellular 
RNA hybridization kinetics. The conditions of hybridization (70% formamide, 0.4  M  NaCI, 
0.01 M  1,4-piperazinediethane sulfonic acid (PIPES), pH 7.4, 46°C, 500 #g RNA/ml [optical 
density at 260 nm, 10]) were chosen to facilitate RNA-DNA hybridization while minimizing 
DNA-DNA hybridization (31, 32). 0.1-ml samples were denatured at 110°C for 1 min and then 
cooled in an ice bath. At various times after incubation at 46°C, 10-/tl samples were removed, 
and the radioactivity in single-stranded nucleic acid and DNA-RNA duplexes was determined 
by hydroxylapatite chromatography. The buffer used for elution of single-stranded nucleic acid 
was 0.14  M  phosphate buffer (pH  7), 0.1% SDS and 0.1  M  NaCI, and the buffer used for 
elution of DNA-RNA hybrids was 0.3 M phosphate buffer (pH 7) and 0.1  M NaCI. 
MCMV Nuclear RNA-MCMV DNA Hybridization.  At  18 h after infection with MCMV, cells 
were pulse-labeled for 45 rain with [3H]uridine (New England Nuclear). The cells were washed 
with  PBS,  dispersed by trypsinization, and then washed  with TNM buffer. The cells  were 
disrupted by resuspension in 0.1% Nonidet P-40 in TNM buffer. After  10  min at  4°C, the 
nuclei were pelleted at 1,500 g for 5 min and resuspended in a high-salt buffer (0.5 M NaC1, 10 
mM Tris, 50 mM MgCI2, pH  7.4). The nuclei were digested with DNase (100/tg/10  ~ cells at 
37°C for 30 min) that had been treated with iodoacetate to remove RNase (33). Three volumes 
of sodium acetate (pH 5) and EDTA were added to the digested nuclei to a final concentration 
of 100 and 10 mM, respectively. The nuclei were disrupted by the addition of SDS to 0.5%, and 
the RNA was extracted twice with phenol at 65°C and once with chloroform-isoamyl alcohol 
(24:1). The RNA was precipitated with ethanol overnight at -20°C, dissolved  in 10 mM Tris, 
I0 mM EDTA, pH 7.4 buffer, and precipitated in 2 M LiCI overnight at 4°C. The RNA was 
fragmented by dissolving in 10 mM Tris-10 mM EDTA buffer, adding NaOH to 0.2 N, and 
incubating  30 min at 4°C. The RNA solution was neutralized by the addition of HEPES buffer 
to 0.4 M. 
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the supernatant medium of infected mouse embryo cells (16). In brief, MCMV  was pelleted by 
centrifugation at 30,000 rpm for 1 h  in a Type-35 rotor (Beckman Instruments, Inc., Palo Alto, 
Calif.) and purified by equilibrium centrifugation at 44,000 rpm for 2 d  in a  CsCl gradient in 
a  Type-65 rotor. The purified virions were disrupted by adding N-lauryl  sarcosinate to 0.5% 
and heating to  70°C.  MCMV  DNA was  purified  from the disrupted  virions by equilibrium 
centrifugation at  44,000  rpm  for 2  d  in a  CsC1  gradient  in a  Type-65  rotor.  MCMV  DNA 
prepared  in this manner did not contain any detectable cellular DNA,  since nick translated 
probes did not react with uninfected cell DNA in either solution or in Southern blot hybridi- 
zation experiments (data not shown). The concentration of MCMV  DNA was determined by 
optical  density  at  260  nm.  Approximately  30  ~g  of  MCMV  DNA  was  affixed  to  each 
nitrocellulose filter  (25  mm  in  diameter,  0.45  pore size, Millipore Corp.,  Bedford,  Mass.)  by 
alkali denaturation of the DNA in 0.1  N  NaOH,  dilution with  14 vol of 2 M  NaC1, and slow 
suction of this solution through the filters. The filters were washed with six times concentrated 
saline sodium citrate (SSC) and baked for 2 h in a vacuum oven at 80°C. After prehybridization 
in buffer (0.3 M  NaC1,  10 mM EDTA,  10 mM PIPES, pH 6.5, 0.2% SDS, and I00/~g of yeast 
RNA/ml) for 2 h at 65°C, the buffer was withdrawn and replaced with 0.5 ml of the fragmented 
nuclear RNA in the same hybridization buffer. After incubation for 40 h  at  65°C,  the filters 
were washed twice with twice concentrated SSC at 65°C for 30 min, treated with RNase (5/~g 
of pancreatic RNase and 5  U  of RNase Tx/ml of 2  ×  SSC)  for 30 min at  37°C,  and washed 
again  with twice concentrated  SSC.  After drying,  the  filters were  added  to  vials containing 
Scintiverse (Fisher Scientific Co., Pittsburgh, Pa.) and counted in a  scintillation counter. 
Results 
MCMV  Fails  to  Productively Infect  Undifferentiated but  Does Infect  Differentiated  Cell 
Lines.  We examined the ability of several undifferentiated and  differentiated cell 
lines to replicate MCMV. Undifferentiated cultures of OTT6050AF1 BrdU, F9, and 
PCC4 cells, as well as differentiated cultures of PYS2, OTTF12, and mouse embryo 
fibroblasts  (MEF)  were infected with MCMV  and  assayed for virus replication by 
plaque assay and  immunofluoreseence. The results presented in Table I  show that 
after MCMV infection undifferentiated cells did not produce a significant increase in 
the amount of infectious virus in the culture fluids, and very few of the >200 cells 
TABLE  I 
Infection  of Undifferentiated  and Differentiated Cells with MCMV* 
Cells showing 
Cell line  Differentiation state  0 h  48 h  viral antigens 
at 48 h:~ 
PFU/ml  % 
OTT6050AF1  BrdU  Undifferentiated  2.3 ×  10  a  2.6 X  10  a  <1 
F9  Undifferentiated  5.3 X  10  a  4.7 x  10  a  <1 
PCC4  Undifferentiated  5.0 X 10  a  4.1 X  10  a  <1 
PYS2  Differentiated  1.3 x  104  1.4 X 107  >90 
OTTF12  Differentiated  3.6 X 103  8.9 ×  106  >90 
MEF  Differentiated  4.1 ×  10  a  2.1 ×  107  >90 
* Cells were  infected with  MCMV  at  an  MOI  of 5.  After a  1.5-h  adsorption  period  at  37°C, 
nonadsorbed virus was removed by washing the cells  three times with medium. A supernatant 
sample was taken immediately after washing 0  h) and after 48 h  of incubation of the infected 
cells at 37°C. Infectious virus was measured by plaque assay on monolayers of BALB/St mouse 
embryo  fibroblasts.  The  presence  or  absence  of  MCMV  cytoplasmic  antigens  in  cells  was 
determined by indirect immunofluorescence assay as described in the text. Similar results were 
seen in a repeated experiment. 
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examined  from each line expressed  viral antigens.  In contrast, the differentiated  cell 
lines  produced  infectious  virus  in  the  culture  fluids,  and  a  majority  (>90%)  of the 
cells  from  each  differentiated  line  produced  viral  antigens.  The  results  show  that 
undifferentiated  cells are refractory to MCMV  infection, whereas differentiated  cells 
are permissive to MCMV  and make infectious MCMV. 
Differentiation  of PCC4  Cells  by  DMA.  We  examined  the  response  to  MCMV 
infection of a  pluripotent  cell  line  in  both  an  undifferentiated  and  a  differentiated 
state. For these studies, we used the PCC4 cell line that can be induced to differentiate 
by  treatment  with  DMA  (22).  First,  we  examined  PCC4  cells  propagated  in  the 
presence and absence of DMA for their content of H-2  b antigens as a  marker for cell 
differentiation  (other undifferentiated  cells lack H-2 antigens)  (34,  35).  Fig.  1 shows 
that PCC4 cells propagated in the absence of DMA do not express H-2  b antigens.  In 
contrast,  PCC4 cells grown in the presence of 10 mM DMA for 3  d  expressed  H-2  b 
antigens. Specificity controls included the use of monospecific antibodies to H-2  b and 
H-2  k,  appropriate  H-2  b and  H-2  k targets  for study,  and  experiments  showing  that 
absorption  with  H-2  k  spleen  cells  did  not  change  the  cytotoxic  activity,  whereas 
absorption with  H-2  b spleen  cells significantly removed cytotoxicity activity.  For all 
subsequent  experiments we used the presence of H-2  b antigens on the cell's surface to 
confirm  the  state  of cell  differentiation.  As  seen  in  Fig.  2,  MCMV  replicated  in 
differentiated  PCC4 cells but failed to make infectious virus in these cells when they 
were in the undifferentiated state. 
Several Viruses Other  Than MCMV Replicate  in  Undifferentiated and Differentiated  PCC4 
Cells.  Next,  we examined  the  ability  of undifferentiated  and  differentiated  PCC4 
cells to replicate  a  variety of viruses.  PCC4 cells  either  undifferentiated  or differen- 
tiated with DMA were permissive to VSV, LCMV, and herpes simplex virus type  1. 
Fig. 2 shows that VSV, LCMV, and herpes simplex virus replicated to an equivalent 
extent in undifferentiated and differentiated  PCC4 cells. In contrast, undifferentiated 
PCC4 cells  infected  with  MCMV  did  not  produce infectious  MCMV  in  the super- 
natant fluids, whereas differentiated PCC4 cells produced almost  107 PFU/ml. These 
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FIo.  2.  PCC4  cells  were  propagated  for  4  d  at  37°C  in  the  presence  (differentiated  cells, 
0----0)  or absence (undifferentiated cells, C)- -  -C)) of 10 mM DMA. The state of differentiation 
was determined by the presence of H-2  b antigens on the cell's  surface (see Fig.  1). Cultures were 
infected with VSV, LCMV, HSV- 1, or MCMV at an MOI of 1. Supernatant samples were removed 
immediately after adsorption (0 d)  and at  1 and 2 d  after infection. The titers of infectious virus 
were determined by plaque assays on Vero cells  (VSV and LCMV), human fibroblasts (HSV-I), 
and mouse embryo fibroblasts (MCMV). 
undifferentiated cells inoculated with MCMV did not produce a significant increase 
in the amount of infectious virus during the 4 d  of observation  (data not shown  for 
days 3 and 4 postinfection). 
Block in the MCMV Infection of Undifferentiated Cells Is in  Viral  RNA Transcription.  To 
determine the stage at which virus infection was blocked in undifferentiated cells, we 
examined the binding of radiolabeled MCMV to cells (adsorption), the transport of 
MCMV  DNA to the cell nucleus and the presence of MCMV DNA, MCMV  RNA 
(transcription), and MCMV proteins (translation)  in undifferentiated cells after viral 
inoculation.  The  results  presented  in  Fig.  3  show  that  [3H]MCMV  bound  equally 
well  to  undifferentiated  PCC4  cells,  differentiated  PCC4  cells,  and  mouse embryo 
fibroblasts. Thus, MCMV adsorbs to the nonpermissive undifferentiated  PCC4 cells 
as efficiently as to the permissive differentiated PCC4 cells or to the permissive mouse 
embryo fibroblasts. 
The results in Table II show that the majority of the [ZH]thymidine-labeled MCMV 
DNA was detected in the nuclei of undifferentiated or differentiated PCC4 cells at 6 
h  after  infection.  These  data  suggest  that  MCMV  can  adsorb,  penetrate,  and  be 
transported  to the nucleus of undifferentiated  PCC4 cells and that  the block in the 
MCMV  infection  of  undifferentiated  cells  is  not  at  any  of these  early  stages  of 
infection. 
We then examined MCMV-infected undifferentiated  PCC4 cells for the presence 
of viral gene products.  Fig.  4  shows  that  undifferentiated  PCC4  cells infected with 
MCMV  did  not  produce detectable amounts of viral antigens.  On  the other hand, 
differentiated PCC4 cells infected with MCMV produced viral antigens. 
Next, we investigated whether undifferentiated  PCC4 cells infected with MCMV 
contained viral DNA or viral RNA. We separately analyzed DNA and RNA harvested 
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Fxo.  3.  2 million cells (Q, differentiated cells propagated in the presence of l0 mM DMA for 4 d; 
O, undifferentiated cells propagated in the absence of DMA; I-1, mouse embryo fibroblasts) were 
exposed for various times at 37°C to [3H]thymidine-labeled mouse cytomegalovirus. The cells were 
centrifuge-washed five times, lysed by resuspension in 1% SDS, added to scintillation cocktail, and 
counted in a scintillation counter. The counts per minute minus the background was plotted vs. the 
time at 37°C. State of differentiation of PCC4 cells was confirmed by analyzing the expression of 
H-2  b antigens on the cell's surface (see Fig.  1). 
TABLE II 
Cellular Fractionation of Undifferentiated and Differentiated PCC4 Cells Infected 
with [aH]MCMV* 
Hours after infection 
PCC4 Cells  1 h  6 h 
Nucleus  Cytoplasm  Nucleus  Cytoplasm 
cpm 
Undifferentiated  150  613  904  113 
Differentiated  201  757  781  212 
PCC4 cells were grown on 60-mra culture dishes either without DMA (undifferen- 
tiated) or with 10 mM DMA for 3 d (differentiated). Cells were infected with 20,000 
cpm of [ZH]thymidine-labeled MCMV at an MOI of 5. At 1 and 6 h after infection, 
the cells were resuspended in 0.1% Nonidet P-40 and separated by centrifugation 
into cytoplasmic and  nuclear  components.  The  trichloroacetic acid-precipitable 
radioactivity in the supernatant (cytoplasm) and the pellet (nuclei) was determined. 
The state of PCC4  differentiation was confirmed by assaying expression of H-2  b 
antigens on the cell's surface (see Fig.  1), 
DNA  probe.  Table  III  shows  that  infected  undifferentiated  PCC4  cells  contained 
detectable  MCMV  DNA  but  did  not  possess  detectable  MCMV  RNA  in  the  cell 
cytoplasm.  In contrast, both  differentiated PCC4  cells and  mouse embryo  fibroblasts 
infected with MCMV  contained  viral DNA  and  viral RNA. 
To  determine  whether  MCMV-infected  undifferentiated  cells  contained  any  de- 
tectable MCMV  RNA  in the nucleus, we pulse-labeled cells with [ZH]uridine, isolated 
the  nuclear  RNA  fraction,  and  hybridized  this  RNA  to  nitrocellulose  filters  that 
contained  MCMV  DNA.  The  results  presented  in  Table  IV  show  that  MCMV- 
infected undifferentiated  PCC4  cells did produce  detectable  MCMV  RNA  at  ~  17% 
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FIG. 4.  Detection of MCMV antigens  in infected differentiated  or undifferentiated  PCC4 cells. 
PCC4 cells were either induced to differentiate by propagation for 3 d with  10 mM DMA (A) or 
maintained as undifferentiated cells by propagation without DMA (B). The cells were infected with 
MCMV at an MOI of 1. At 24 h after infection, the cells were examined for cytoplasmic MCMV 
antigens by indirect immunofluorescence. × 360. 
results  demonstrate  that  some  MCMV  RNA  is  transcribed  but  that  a  significant 
block in  the  MCMV  infection of undifferentiated  PCC4  cells occurs  at  the  level of 
RNA transcription. 
Establishment  of an  MCMV Latent  Infection in  Undifferentiated Cells and  Activation  of 
MCMV  during PCC4  Cell  Differentiation.  Undifferentiated  PCC4  cells  adsorbed 
MCMV  and  contained  viral  DNA  but  did  not  produce  infectious  virus,  whereas 
differentiated  PCC4  cells  made  infectious  virus.  Thus,  we  determined  whether  a 
model  of  latent  infection  with  subsequent  virus  activation  and  infectious  virus 
production  could  be  established  by  inducing  undifferentiated  cells  infected  with 
MCMV  to  differentiate.  Undifferentiated  PCC4  cells were  infected  with  MCMV, 
and  any  residual  infectious  virus  was  inactivated  with  antibody  to  MCMV  and 
guinea pig complement. These infected undifferentiated PCC4 cells were then prop- 
agated under subconfluent conditions that maintained the undifferentiated state. No 
infectious virus was detected in the culture fluids. 1 d  later, the cells were subcultured 
either without DMA to maintain the cells as undifferentiated or with DMA to induce 
the cells to differentiate. Uninfected PCC4 cells were cultured in a  similar manner. At 
0,  2,  3,  and  4  d  after infection, the cells were analyzed  for their content  of MCMV 
DNA, for the presence of MCMV  antigens, and, for the production of infectious virus. 
Table V  shows the data from one of three representative experiments. When MCMV- 
infected PCC4 cells were cultured without  DMA, infectious virus was not detectable 
until 3 and 4  d  after infection. The presence of a  small amount  (3.3 X  101 PFU/ml  at 
day 3 postinfection) of infectious virus correlated with a  small increase in the MCMV 
DNA genome equivalent per cell from 0.02  (day 2)  to 0.12  (day 3), as well as with an 
increase in  the  number  of cells positive for  MCMV  antigens  from  0.7%  (day  2)  to 
2.4%  (day 3).  Inasmuch  as spontaneous differentiation occured in  ~3%  of these cells 1644  LATENT CYTOMEGALOVIRUS  INFECTION  OF UNDIFFERENTIATED  CELLS 
TABLE III 
Detection of MCMV DNA m the Nucleus or MCMV RNA in the Cytoplasm of 
MCMV-infected Undifferentiated  and Differentiated PCC4 Cells* 
To de- 
tect 
MCMV 
State of differentia- 
Culture  tion 
Double-stranded nucleic acid at hour 
of hybridization 
Oh  lh  2h  3h 
DNA 
% 
Uninfected  Undifferentiated  0.0  4.8  13.0  20.0 
Uninfected  Differentiated  0.0  3.5  12.3  18.1 
Infected  Undifferentiated  0.0  37.5  50.0  58.3 
Infected  Differentiated  0.0  51.2  64.3  73.3 
Oh  20h  96h 
RNA 
% 
Uninfected  Undifferentiated  7.5  7.8  8.1 
Uninfected  Differentiated  7.6  7.7  8.3 
Infected  Undifferentiated  7.9  7.9  8.5 
Infected  Differentiated  7.8  23.6  25.1 
* PCC4 ceils were incubated with or without 10 mM DMA for 3 d at 37°C and then infected 
with MCMV at an MOI of 5.  After adsorption for  1.5 h  at 37°C, the cells were washed 
and then incubated at 37°C with MEM.  16 h later, DNA was isolated from one group and 
RNA from another group of cells. The DNA samples were analyzed for MCIVIV DNA by 
the phenol emulsion reassociation technique with MCMV [aH]DNA probe, and the RNA 
samples were analyzed for MCMV RNA by MCMV [ZH]DNA-RNA hybridization in the 
presence of formamide as described in the text. The amount of probe (MCMV [aH]DNA) 
in double-stranded form was determined by hydroxylapatite chromatography. Equivalent 
results were obtained in three repeat experiments. The state of PCC4 differentiation was 
monitored by assaying H-2  b antigen expression on the cell's surface. 
TABLE IV 
Detection of MCMV RNA in the Nucleus of MCMV-infected  Undifferentiated  and 
Differentiated PCC4 Cells * 
Culture  State of differentiation  cpm bound 
cpm (infected) 
-- cpm (unin- 
fected) 
Uninfected  Undifferentiated  1,284  -- 
Uninfected  Differentiated  1,466  -- 
Infected  Undifferentiated  3,144  1,860 
Infected  Differentiated  12,652  11,186 
* Culture dishes (175 cm  2) of PCC4 cells propagated without  (undifferentiated)  or 
with  10 mM DMA for 3  d  (differentiated)  were either mock infected or infected 
with MCMV at an MOI  of 5. At  18 h  after infection, the medium was decanted 
of [ H]uridine per dish. After  and replaced with I0 ml of medium containing 3 mCi  a 
45 min of incubation at 37°C, the nuclear RNA fraction was isolated. MCMV RNA 
was  detected  by  hybridization  to  nitrocellulose  filters  containing either  purified 
MCMV DNA or no DNA (blank filters). The hybridization conditions were 40 h at 
650C in a  buffer consisting of 0.3 M  NaC1, 10 mM EDTA, 10 mM PIPES, pH 6.5, 
0.2% SDS, and 100/.tg of yeast RNA/ml. After hybridization, the filters were treated 
with RNase, dried, and counted in a scintillation counter. Counts per minute (cpm) 
bound is the average of the cpm bound to duplicate filters that contained MCMV 
DNA minus the cpm bound to duplicate blank filters. Similar results were obtained 
in three repeat experiments. The state of differentiation was monitored by assaying 
H-2  b antigens expressed on the cell's surface. FRANCIS J.  DUTKO  AND MICHAEL B. A. OLDSTONE 
TABLE  V 
Activation of Latent MCMV  from Undifferentiated PCC4 Cells Occurs during 
Cell Differentiation* 
1645 
Culture  Day postin-  MCMV DNA  Ceils positive  Plaque-forming 
genome equiva-  for MCMV  units per milliliter 
fection  lents per cell  antigen 
% 
-DMA  0  <0.01  0  < 10 
-  DMA  2  0.02  0.7  < 10 
-DMA  3  0.12  2.4  3.3 ×  10  a 
-DMA  4  0.11  2.1  4.0 x  102 
+DMA  2  0.01  3.4  1.6 x  l0  s 
+DMA  3  0.37  17.2  1.0 x  l0  s 
+DMA  4  1.20  75.0  6.0 ×  105 
Undifferentiated  PCC4  cells were  infected  for  1.5  h  at  370C  at  an  MOI  of  10. 
Residual infectivity was removed by incubating cells for 30 rain at 37°C with mouse 
antisera  to  MCMV  and  guinea  pig  complement.  A  sample  of  cells  and  the 
supernatant  fluid  was  removed  at  this  time  (day  0  postinfection).  The  infected 
undifferentiated cells were propagated for 24 h  under conditions that  maintained 
the majority of the cells in an undifferentiated state. At 1 d  after infection, 5 ×  10  ~ 
cells were seeded into each of several 250-ml Erlenmeyer flasks containing 50 ml of 
medium, with or without  10 mM DMA. At 2, 3, and 4 d after infection, samples of 
both  supernatant  fluids  and  cells  were  taken.  Supernatants  were  analyzed  for 
infectious virus  (plaque-forming units)  by plaque  assay on  MEF.  The cells were 
analyzed for MCMV DNA by the hybridization technique described in the text. In 
addition, the cells were pelleted onto glass slides and fixed with ether-alcohol, and 
200 cells were examined for MCMV antigens by indirect immunofluorescence. The 
state of PCC4  differentiation was  monitored  by assaying the expression of H-2  b 
antigens on the cell's surface. 
by day 3, the infectious virus detected in undifferentiated cell cultures probably came 
from cells that spontaneously differentiated as the cultures became overconfluent. In 
contrast, when MCMV-infected PCC4 cells were cultured with DMA to induce cell 
differentiation, infectious virus was detectable at 2 d after infection (1.6 ×  102 PFU/ 
ml)  and reached 6.0 ×  105 PFU/ml at 4  d  after infection, the majority of the cells 
(>75%)  contained  MCMV  antigens  (Fig.  5),  and  the  cells  contained  1.2  MCMV 
DNA genome equivalents/cell. 
Discussion 
In this paper we report two new observations. First, MCMV cannot productively 
infect several undifferentiated cell lines tested. Although virus can adsorb to undiffer- 
entiated  ceils and  viral  DNA  is  detected in  the cell nucleus,  complete viral  RNA 
transcription,  viral  translation,  or  production  of infectious  virus  does  not  occur. 
Second, this observation can be extended to develop a model of MCMV latency and 
activation.  Upon  induction  of cell  differentiation  in  previously  MCMV-infected 
undifferentiated cells, viral transcription and release of infectious virus occur. 
We found that  MCMV could not productively infect undifferentiated cells. This 
finding  was  generalized  to  include  several  undifferentiated  cell  lines  such  as 
OTT6050AF1  BrdU,  F9,  and  PCC4.  In  contrast,  MCMV  did  productively infect 
differentiated teratocarcinoma cell lines such as PYS2 and OTTF12. Although these 
findings were consistent and were observed in repeated experiments with MCMV, 
they are not universal for all herpesviruses. Herpes simpl'ex virus type 1 replicates and 1646  LATENT CYTOMEGALOVIRUS INFECTION OF UNDIFFERENTIATED CELLS 
Ftc.  5.  Detection of MCMV antigens after induction  of cell differentiation  in MCMV-infected 
undifferentiated  cells. Undifferentiated  PCC4 cells were infected with MCMV and propagated as 
described  in  the  legend  to  Table  V.  At  3  d  postinfection  and  after either induction  of cell 
differentiation  with  DMA  (A) or maintenance  of undifferentiation  (B), the cells were allowed to 
attach to  glass slides, fixed with  ether-alcohol,  and examined  for MCMV antigens  by indirect 
immunofluorescence. ×  120. 
makes  infectious  virus  in  undifferentiated  cells  as  well  as  differentiated  cells.  In 
agreement with the observations concerning undifferentiated mouse cells and MCMV 
reported  here,  we  have  recently found  that  human  CMV  also  fails to  productively 
infect  Tera-2  or  PA-1  cells, undifferentiated  human  teratocarcinoma  cell lines, but 
that  it  is  permissive  for  differentiated  lines,  z  The  inability  of  MCMV  to  infect 
undifferentiated cells differs from most other viruses studied, inasmuch  as Coxsackie 
B3  virus, encephaiomyocarditis virus,  murine  hepatitis virus,  Sindbis virus,  Semliki 
Forest virus, LCMV,  Pichinde virus, VSV, herpes simplex virus type 1, and vaccinia 
virus can replicate to a  similar extent in undifferentiated and differentiated cells (36- 
38, Fig. 2). 
It  was of interest to determine  the step at  which MCMV  replication in  undiffer- 
entiated  cells  was  blocked.  Studies  with  radiolabeled  MCMV  indicated  a  similar 
number  of binding sites on  the  undifferentiated  PCC4  cells and  the  differentiated 
PCC4  cells  (Fig.  3),  as  well  as  efficient  transport  of MCMV  DNA  to  the  nucleus 
(Table II). DNA hybridization kinetic experiments detected MCMV  DNA in undif- 
ferentiated cells, but  immunofluorescence  results indicated that  viral antigens  were 
not  made  in  these  cells.  Furthermore,  infectious  virus  was  not  produced.  MCMV 
DNA-cellular  RNA  hybridization  experiments  failed  to  show  viral  RNA  in  the 
cytoplasm  from  MCMV-infected  undifferentiated  cells.  However,  a  low  level  of 
MCMV  RNA could be detected in the nucleus by a  pulse-labeling assay. Thus,  the 
block in  the  MCMV  infection  of undifferentiated  PCC4  cells appears  to  be  at  the 
level of RNA transcription. The finding of MCMV  RNA  in the nucleus of undiffer- 
entiated  cells  (Table  IV)  suggests  that  a  portion  of  the  viral  genome  may  be 
transcribed. Experiments  to  determine which  regions of the genome are transcribed 
in undifferentiated cells, the presence or absence of early MCMV  antigens, and  the 
reason(s)  for failure of viral RNA transcription are currently underway. 
The  mechanism(s)  involved  in  the  block in  viral  RNA  transcription  in  MCMV- 
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infected undifferentiated cells is unknown, but it may be due to a deficiency in RNA 
splicing. Indeed, our findings with MCMV in undifferentiated teratocarcinoma cells 
are reminiscent of the findings of others in similar cell lines with SV40. SV40 fails to 
replicate  in  F9  undifferentiated  cells,  but  the  block  is  not  at  the  level  of virus 
adsorption,  penetration, uncoating,  or transport  to the nucleus  (39).  Such  F9 cells 
infected with SV40 produce an unspliced early viral RNA transcript that is unstable 
(40).  When  F9  cells  were  induced  to  differentiate  with  retinoic  acid  (41),  they 
produced stable spliced early SV40 mRNAs (42). Further, it is of interest to compare 
our  findings  with  those  obtained  from  herpes  simplex  virus  latency  in  vivo  in 
trigeminal  ganglia.  Using nucleic acid hybridization techniques,  Puga and  his col- 
leagues (43) noted the presence of herpes simplex virus DNA but not viral RNA and 
postulated a molecular lesion in RNA transcription. 
Very few viruses cannot productively infect undifferentiated cells while possessing 
the ability to infect differentiated cells.  Polyoma virus can adsorb to undifferentiated 
cells and viral DNA is transported to the nucleus, but T  or V  antigens are not made 
(39, 44, 45). The nature of the block may be at viral RNA synthesis, since a low level 
of spliced viral RNA can be detected in polyoma virus-infected PCC4 cells (46, 47). 
Several murine leukemia viruses were also unable to productively infect undifferen- 
tiated  cells, but  could productively infect differentiated cells  (37,  48,  49).  Proviral 
DNA, but no infectious virus, was detected in undifferentiated cells (37). The minute 
virus of mice also fails to productively infect undifferentiated cells (50). 
Using infected undifferentiated PCC4 cells, we were able to develop a  model of 
CMV latency and subsequent  activation. Whereas undifferentiated cells previously 
infected with MCMV failed to make infectious virus over several days in culture, the 
induction of cell differentiation resulted in the production of MCMV RNA, protein, 
and infectious virus. 
This model of CMV in undifferentiated cells offers several unique opportunities for 
understanding both latency and  MCMV  infection. First,  teratocarcinoma cells are 
similar to cells of the early mouse embryo in their potential to differentiate and  in 
many of their surface antigens. Early mouse embryos are resistant to MCMV infection, 
whereas  later-stage  embryos are susceptible  (51).  Hence, study of teratocarcinoma 
cells in vitro and in vivo may provide leads for the understanding of CMV-associated 
birth defects. Second, several pluripotent teratocarcinoma cell lines can be induced to 
differentiate in vitro into cells of the embryonic ectoderm, endoderm, and mesoderm. 
The infection of such  differentiated cells and  precursor undifferentiated cells with 
MCMV  may help lead to the control of viral and host gene expression in different 
cell types. Third, understanding the defect in MCMV replication in undifferentiated 
teratocarcinoma cells  should  allow  the  production  and  utilization  of appropriate 
nucleic acid probes for the study of latent CMV infection in vivo. This information 
will be of value in understanding human CMV disease. 
Summary 
Murine  cytomegalovirus  (MCMV)  does  not  productively  infect  OTT6050AF1 
BrdU, F9, or PCC4 undifferentiated murine teratocarcinoma cell lines, as shown by 
immunofluorescence assays for viral antigens and by plaque assays for infectious virus. 
However,  these  cells  were  infected  by  a  variety  of other  viruses.  MCMV  does 1648  LATENT CYTOMEGALOVIRUS  INFECTION OF UNDIFFERENTIATED CELLS 
productively  infect  PYS2  and OTT  F12  differentiated  murine  teratocarcinoma  cell 
lines. 
The  replication  of MCMV  in  the  pluripotent  PCC4  cell  line  was  examined  in 
detail.  Undifferentiated  PCC4 cells could be differentiated  when  propagated  in the 
presence ofdimethylacetamide, as judged by changes in the expression of H-2 antigens 
on  the  cell  surface.  Several  viruses,  including  lymphocytic  choriomeningitis  virus, 
herpes  simplex  virus  type  1,  and  vesicular  stomatitis  virus,  replicated  to  a  similar 
extent  in  differentiated  and  undifferentiated  PCC4  cells.  MCMV  did  productively 
infect differentiated  PCC4 cells. In contrast, MCMV did not produce infectious virus, 
viral antigens, or substantial  viral RNA in undifferentiated  PCC4 cells. 
The molecular block of MCMV  replication occurred at the level of MCMV  RNA 
transcription.  Undifferentiated  PCC4  cells  have  receptors  for  MCMV  and  bind 
similar  amounts  of radiolabeled  virus  as  differentiated  PCC4  cells.  After  MCMV 
binds to its receptors on undifferentiated  cells, MCMV  penetrates  the plasma mem- 
brane  and  is  transported  to  the  cells'  nuclei.  MCMV  DNA  was  present  in  the 
cytoplasm,  and  small  amounts  of MCMV  RNA  (<17%  of that  found  in  MCMV- 
infected  differentiated  PCC4  cells)  were  found  in  the  nucleus.  However,  MCMV 
RNA was not detected  in the cytoplasm of undifferentiated  cells. 
A  latent  infection  was  established  by  infecting  undifferentiated  PCC4  cells  with 
MCMV, inactivating residual infectivity with antibodies to MCMV, and propagating 
cells  under  conditions  that  maintained  the  undifferentiated  state.  These  MCMV- 
infected undifferentiated cells did not produce infectious virus, viral antigens, or viral 
RNA but  did  contain  viral  DNA  detectable  by DNA-DNA hybridization  kinetics. 
Latency was terminated  and  infectious  virus was made  when  such  undifferentiated 
cells were induced to differentiate. 
We wish to thank Cathy Booher for excellent technical assistance and Susan Edwards for the 
preparation of the manuscript. 
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